Other news to note
Basilea Pharmaceutica Ltd., of Basel, Switzerland, said the FDA designated isavuconazole as a qualified infectious disease product for the treatment of invasive mucormycosis, a life-threatening invasive fungal infection caused by certain emerging molds.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter